dc.contributor.author | Kurtoglu, M | en_US |
dc.contributor.author | Davarpanah, NN | en_US |
dc.contributor.author | Qin, R | en_US |
dc.contributor.author | Powles, T | en_US |
dc.contributor.author | Rosenberg, JE | en_US |
dc.contributor.author | Apolo, AB | en_US |
dc.date.accessioned | 2016-02-02T15:45:39Z | |
dc.date.available | 2015-02-27 | en_US |
dc.date.issued | 2015-10 | en_US |
dc.date.submitted | 2016-01-13T14:28:28.811Z | |
dc.identifier.issn | 1558-7673 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/11013 | |
dc.format.extent | 410 - 420 | en_US |
dc.relation.ispartof | CLINICAL GENITOURINARY CANCER | en_US |
dc.rights | doi:10.1016/j.clgc.2015.02.009 | |
dc.subject | Bladder cancer | en_US |
dc.subject | Clinical trials | en_US |
dc.subject | Immune checkpoints | en_US |
dc.subject | Novel agents | en_US |
dc.subject | Targeted therapy | en_US |
dc.title | Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1016/j.clgc.2015.02.009 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360914600011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 5 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 13 | en_US |